standard-title Investors



Reprogene is a clinical genetics facility, independently and privately owned that is CLIA and state certified, specializing in detecting human chromosomal abnormalities, genetic diseases and disorders. Our industry is evolving rapidly to promise a healthier future for reproductive genetics, the fastest growing segment. With international recognition through patented technologies and a growing number of clients, Reprogene always maintains the most innovative technologies to keep up with global demands.


Info | If you are interested in the possibility of becoming an investor, please contact us at